Identification of membrane progestin receptors in human breast cancer cell lines and biopsies and their potential involvement in breast cancer

Steroids

Volumn 72, Issue 2, 2007, Pages 111-116

  Dressing, Gwen E ^a   Thomas, Peter ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Alternative progesterone signaling pathways; Breast cancer; Membrane progesterone receptor; mPR; Progesterone action

Indexed keywords

MEMBRANE RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR BIOPSY;

BIOPSY; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; RECEPTORS, CELL SURFACE; RECEPTORS, PROGESTERONE;

EID: 33847061304     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2006.10.006     Document Type: Article

References (29)

1. Losel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H.C., Rossol-Haseroth K., et al. Nongenomic steroid action: controversies, questions, and answers. Physiol Rev 83 (2003) 965-1016
2. Razandi M., Pedram A., Merchenthaler I., Greene G.L., and Levin E.R. Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 18 (2004) 2854-2865
3. Zhu Y., Rice C.D., Pang Y.F., Pace M., and Thomas P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc Natl Acad Sci USA 100 (2003) 2231-2236
4. Zhu Y., Bond J., and Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 100 (2003) 2237-2242
5. Thomas P, Pang Y, Groenen P, Kelder J, Dong J, Zhu Y, et al. Steroid and G Protein binding characteristics of the seatrout and human progestin membrane receptor alpha subtypes and their evolutionary origins. Endocrinology; in press.
6. Karteris E, Zervou S, Pang Y, Dong J, Hillhouse EW, Randeva HS, et al. Progesterone signaling in human myometrium through two novel membrane G protein coupled receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol; 2006.
7. MacMahon B., and Feinleib M. Breast cancer in relation to nursing and menopausal history. J Natl Cancer Inst 24 (1960) 733-753
8. Chlebowski R.T., Hendrix S.L., Langer R.D., Stefanick M.L., Gass M., Lane D., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289 (2003) 3243-3253
9. Li C.I., Weiss N.S., Stanford J.L., and Daling J.R. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women. Cancer 88 (2000) 2570-2577
10. Schairer C., Lubin J., Troisi R., Sturgeon S., Brinton L., and Hoover R. Estrogen-progestin replacement and risk of breast cancer. JAMA 284 (2000) 691-694
11. Persson I., Weiderpass E., Bergkvist L., Bergstrom R., and Schairer C. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 10 (1999) 253-260
12. Ross R.K., Paganini-Hill A., Wan P.C., and Pike M.C. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92 (2000) 328-332
13. McGowan E.M., Saad S., Bendall L.J., Bradstock K.F., and Clarke C.L. Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts. Breast Cancer Res Treat 83 (2004) 211-220
14. Mote P.A., Bartow S., Tran N., and Clarke C.L. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 72 (2002) 163-172
15. Keen J.C., and Davidson N.E. The biology of breast carcinoma. Cancer 97 (2003) 825-833
16. Fink L., Seeger W., Ermert L., Hanze J., Stahl U., Grimminger F., et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 4 (1998) 1329-1333
17. Pace M.C., and Thomas P. Activation of a pertussis toxin-sensitive, inhibitory G-protein is necessary for steroid-mediated oocyte maturation in spotted seatrout. Dev Biol 285 (2005) 70-79
18. Hanna R., Pang Y., Thomas P., and Zhu Y. Cell-surface expression, progestin binding, and rapid nongenomic signaling of zebrafish membrane progestin receptors alpha and beta in transfected cells. J Endocrinol 190 (2006) 247-260
19. Thomas P., Pang Y.F., Zhu Y., Detweiler C., and Doughty K. Multiple rapid progestin actions and progestin membrane receptor subtypes in fish. Steroids 69 (2004) 567-573
20. Pace M.C., and Thomas P. Steroid-induced oocyte maturation in Atlantic croaker (Micropogonias undulatus) is dependent on activation of the phosphatidylinositol 3-kinase/Akt signal transduction pathway. Biol Reprod 73 (2005) 988-996
21. Lange C.A., Richer J.K., and Horwitz K.B. Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 13 (1999) 829-836
22. Shen T., Horwitz K.B., and Lange C.A. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol Cell Biol 21 (2001) 6122-6131
23. Alkhalaf M., and El-Mowafy A.M. Overexpression of wild-type p53 gene renders MCF-7 breast cancer cells more sensitive to the antiproliferative effect of progesterone. J Endocrinol 179 (2003) 55-62
24. Thomas P., Pang Y., Filardo E.J., and Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 (2005) 624-632
25. Torres-Arzayus M.I., Font de Mora J., Yuan J., Vazquez F., Bronson R., Rue M., et al. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6 (2004) 263-274
26. Mussi P, Yu C, O'Malley BW, Xu J. Stimulation of steroid receptor coactivator-3 (SRC-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3. Mol Endocrinol; 2006.
27. Thomas W., Coen N., Faherty S., Flatharta C.O., and Harvey B.J. Estrogen induces phospholipase A2 activation through ERK1/2 to mobilize intracellular calcium in MCF-7 cells. Steroids 71 (2006) 256-265
28. Lee W.J., Monteith G.R., and Roberts-Thomson S.J. Calcium transport and signaling in the mammary gland: targets for breast cancer. Biochim Biophys Acta 1765 (2006) 235-255
29. Ashley R.L., Clay C.M., Farmerie T.A., Niswender G.D., and Nett T.M. Cloning and characterization of an ovine intracellular seven transmembrane receptor for progesterone that mediates calcium mobilization. Endocrinology 147 (2006) 4151-4159